Engaged in research on comprehensive treatment of breast cancer, immunotherapy for triple-negative breast cancer, and postoperative breast reconstruction for breast cancer.

breast cancer

Postdoc of Breast Surgery, Sun Yat-Sen University Cancer Center, China, 2021-2023 
M.D. of Oncology, Sun Yat-Sen University , China, 2019-2021 
Bachelor of Medicine ,  Sun Yat-Sen University , China, 2013-2019 
1.BAG2 drives chemoresistance of breast cancer by exacerbating mutant p53 aggregate. Xinjian Huang , Dongni Shi , Xuxiazi Zou , Xuxia Wu , Shumei Huang, Lingzhi Kong , Muwen Yang , Yunyun Xiao , Boyu Chen , Xiangfu Chen , Ying Ouyang , Libing Song , Yunting Jian , Chuyong Lin.  Theranostics. 2023 (IF=12.4).
2.Efficacy and predictive factors of immune checkpoint inhibitors in metastatic breast cancer: a systematic review and meta-analysis.Yutian Zou , Xuxiazi Zou , Shaoquan Zheng , Hailin Tang , Lijuan Zhang , Peng Liu , Xiaoming Xie .Therapeutic Advances in Medical Oncology. 2020 (IF=8.2)
3.Investigating Mechanisms of Response or Resistance to Immune Checkpoint Inhibitors by Analyzing Cell-Cell Communications in Tumors Before and After Programmed Cell Death-1 (PD-1) Targeted Therapy: An Integrative Analysis Using Single-cell RNA and Bulk-RNA Sequencing Data. Yi-Quan Jiang , Zi-Xian Wang , Ming Zhong , Lu-Jun Shen , Xue Han , Xuxiazi Zou , Xin-Yi Liu , Yi-Nan Deng , Yang Yang , Gui-Hua Chen , Wuguo Deng , Jin-Hua Huang . OncoImmunology.  2021 (IF=7.7)

4.Peripheral blood lymphocytes subtypes as new predictors for neoadjuvant therapy efficacy in breast cancer. Jikun Feng , Jiarong Yi , Xiazi Zouxu , Jianxia Li , Zhenchong Xiong , Xinjian Huang , Wenjing Zhong , Weiling Huang , Feng Ye , Xi Wang. Cancer Medicine. 2022 (IF=4)

Updated by International Office, Sun Yat-sen University Cancer Center